SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories informs about trading window closure

23 Mar 2022 Evaluate
Brooks Laboratories has informed that the trading window of the Company shall remain closed for all Directors/Officers/designated persons of the Company from 31st March, 2022 till 48 hours after the declaration of the Audited Financial Results of the Company for the financial year ended 31st March, 2022. The date of Board Meeting for the declaration of the Audited Financial Results of the Company for the financial year ended 31st March, 2022 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.


Brooks Laboratories Share Price

62.05 -2.61 (-4.04%)
22-Apr-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1657.70
Dr. Reddys Lab 1213.25
Cipla 1227.75
Zydus Lifesciences 927.65
Lupin 2305.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×